Cargando…
Antifungal Liposomes Directed by Dectin-2 Offer a Promising Therapeutic Option for Pulmonary Aspergillosis
Invasive fungal diseases cause millions of deaths each year. There are currently approximately 300,000 acute cases of aspergillosis, most of which result from a pulmonary infection of immunocompromised patients by the common soil organism and opportunistic pathogen Aspergillus fumigatus. Patients ar...
Autores principales: | Ambati, Suresh, Ellis, Emma C., Pham, Tuyetnhu, Lewis, Zachary A., Lin, Xiaorong, Meagher, Richard B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8545082/ https://www.ncbi.nlm.nih.gov/pubmed/33622715 http://dx.doi.org/10.1128/mBio.00030-21 |
Ejemplares similares
-
Dectin-2-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy
por: Ambati, Suresh, et al.
Publicado: (2019) -
Aiming for a bull’s-eye: Targeting antifungals to fungi with dectin-decorated liposomes
por: Meagher, Richard B., et al.
Publicado: (2021) -
Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy
por: Ambati, Suresh, et al.
Publicado: (2019) -
Erratum for Ambati et al., “Dectin-1-Targeted Antifungal Liposomes Exhibit Enhanced Efficacy”
por: Ambati, Suresh, et al.
Publicado: (2019) -
DectiSomes: Glycan Targeting of Liposomal Drugs Improves the Treatment of Disseminated Candidiasis
por: Ambati, Suresh, et al.
Publicado: (2022)